MedTrace Logo

Clinical Study of PRP in the Treatment of Androgenetic Alopecia

NCT07551271 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-04-24

No results posted yet for this study

Summary

A study on the therapeutic effect of platelet-rich plasma in the treatment of androgenetic alopecia

Conditions

  • Androgenetic Alopecia (AGA)

Interventions

DRUG

PRP

group A was treated with platelet-rich plasma combined with external Minoxidil , group B was treated with external Minoxidil

Sponsors & Collaborators

  • The First Affiliated Hospital of Soochow University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-01
Primary Completion
2026-01-01
Completion
2026-03-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07551271 on ClinicalTrials.gov